Skip to content

Investigation of Arm Swings Characteristics in Patient With Chronic Obstructive Pulmonary Disease

Kronik Obstrüktif Akciğer Hastalığında Yürüyüş Sırasında Yürüyüşün Zaman Mesafe Karakteristikleri ve Kol Salınımlarının İncelenmesi

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05746702
Enrollment
40
Registered
2023-02-28
Start date
2023-03-01
Completion date
2024-10-19
Last updated
2023-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Dyspnea, Gait, Unsteady, Postural; Defect

Brief summary

The former aim of this study is to determine whether the arm swings change in patients with Chronic Obstructive Pulmonary Disease (COPD) according to healthy subjects. The latter purposes to investigate the correlation between balance parameters and arm swing, how to change arm swing according to severity of the disease, and to determine the relationship between balance and the severity of disease, the relationship of posture both arm swing and severity of disease in patients with COPD. In accordance with this purposes, 20 patients with COPD who have Global Initiative for Chronic Obstruction Lung Disease (GOLD) stage 1-2-3 and 20 healthy controls will be included between the ages of 40 and 65, respectively. Tests and questionnaires will be used in order to determine the severity of COPD and to evaluate posture. Berg Balance Scale, Time Up and Go Test, 6 Minute Pegboard and Ring Test, 6 Minute Walk Test and gait analysis will be performed. It is expected that by determining the parameters that can be affected by severity of COPD. It is estimate to have information about severity of the disease by means of observational analysis. It will guide professional working in the field.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Who has been clinically stable for the last 4 weeks, * who will be able to walk independently for 6 minutes, * According to the Classification of Airflow Limitation in COPD (GOLD) system, the Stage is 1-2-3, * who declares that he has not taken part in any other research

Exclusion criteria

* walking assistive devices, * receiving chronic oxygen therapy, * with central and peripheral vestibular disease, * with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance, * with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery, * who has communication problems, * with mental and cognitive problems

Design outcomes

Primary

MeasureTime frameDescription
Arm Swings Characteristics1 dayChange of the arm swings during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.

Secondary

MeasureTime frameDescription
Upper Extremity Functional Capacity1 dayUpper extremity functional capacity by 6 minute pegboard and ring test in patient with Chronic Obstructive Pulmonary Disease
Balance1 dayBalance by Berg Balance Scale and Time Up Go Test in patient with Chronic Obstructive Pulmonary Disease
Spatiotemporal Characteristic1 dayChange of the spatiotemporal characteristic during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.
Posture1 dayposture by Corbin Posture Analyses Form in patient with Chronic Obstructive Pulmonary Disease
Functional Exercise Capacity1 dayFunctional exercise capacity by six minute gait test in patients with Chronic Obstructive Pulmonary Disease.
Severity of Disease1 dayseverity of disease by GOLD ( Global İnitiative for Chronic Obstructive Pulmonary Disease) , CAT ( Chronic Respiratory Questionnaire), Pulmonary Function Test in patient with Chronic Obstructive Pulmonary Disease

Countries

Turkey (Türkiye)

Contacts

Primary ContactAynur Demirel, PhD
aynur.demirel@hacettepe.edu.tr+90 3123051576

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026